Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

NCT02210117 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Metastatic Kidney Carcinoma
Stage IV Renal Cell Cancer AJCC v7

Interventions

BIOLOGICAL: Bevacizumab
PROCEDURE: Biopsy
BIOLOGICAL: Ipilimumab
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Metastasectomy
BIOLOGICAL: Nivolumab
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]